WiseGuyReports.Com Publish a New Market Research Report On –“ Specialty Generic Drugs Market Worth 190.9 billion US$ By 2026”.
Specialty Generic Drugs Market 2019
The global Specialty Generic Drugs Market is anticipated to reach USD 190.9 billion by 2025. Specialty Generics drugs are the generic forms of pharmacological drugs. These drugs are economically cheaper in contrast to branded drugs. Even so, development and commercialization of specialty generics drug are more complex when compared with conventional generics drugs. Companies are entering into specialty generic drugs market to manufacture generic forms of the products by forming new drug formulations. In addition, global capacity of conventional or traditional generics drugs market is also forcing companies to seek newer opportunities.
Increase in the number of off-patent specialty drugs is factor estimated to form the lucrative growth in specialty generic drugs market. For instance, the patent for Novartis drug Gilenya is estimated to expire in 2019. This drug has made approximately 14% sales growth of Novartis. Such early patent expirations are expected to boost the global market growth. In addition, the rise in the number of people suffering cancer is anticipated to bolster the global market growth. According to World Health Organization (WHO) 2015, approximately 160,000 individuals in the U.S. were filed to have various cancers. Thus, with the high prevalence of cancer case requiring drugs are anticipated to increase the global specialty generic drugs market growth.
For more information or any query mail at email@example.com
North America is the highest spending region in healthcare, yet, this region started to put cutting healthcare expenditure. The current economic & financial crisis and the existence of a high geriatric population are some of the key reasons for the cost cut in healthcare infrastructure over this region. This creates the need for developing novel, enhanced, and economic methods for production of specialty generics drugs. This factor is further anticipated boost the global specialty generic drugs market in the forecast period.
Some of the major key players operating in global specialty generic drugs market are Mylan N.V., Teva Pharmaceuticals USA, Inc., Sandoz International GmbH, Mallinckrodt, Akorn Inc., Valeant Pharmaceuticals International Inc., Endo Pharmaceuticals Inc. Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Apotex Corp. among others
This report mentions various factors that are causative of fast-paced expansion of the Specialty Generic Drugs market. This includes a detailed study of the pricing history of the product/service, the value of the product/service, and numerous volume trends. Some principal factors studied in the report include the influence of mounting population on a global level, burgeoning technological advancements, and the dynamics of demand and supply noted in the Specialty Generic Drugs market. Additionally, it also studies the impact of various government initiatives and the competitive landscape existing in the Specialty Generic Drugs market through the forecast period.
The report includes segmentation of the Specialty Generic Drugs market on the basis of different aspects, along with a regional segmentation. Such segmentation has been carried out with the perspective of attaining detailed and accurate insights into the Specialty Generic Drugs market. The report studies the regional segments of Latin America, North America, Asia Pacific, Europe, and the Middle East & Africa.
The market research team has analyzed the global Specialty Generic Drugs market by adopting Porter’s Five Force Model for the assessment period of 2019-2026. Furthermore, an in-depth SWOT analysis is carried out to enable faster decision making of the reader about the Specialty Generic Drugs market.
Table Of Contents – Major Key Points
- Overview and Scope
- Executive Summary
- Specialty Generic Drugs Market Insights
- Specialty Generic Drugs Market Size and Forecast by Application
- Specialty Generic Drugs Market Size and Forecast by Route of Administration
- Specialty Generic Drugs Market Size and Forecast by Distribution Channel
- Specialty Generic Drugs Market Size and Forecast by Regions
- Company Profiles
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.